交易 Virios Therapeutics, Inc. - VIRI CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.05 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Mar 27, 2024 | 0.45 | 0.01 | 2.27% | 0.44 | 0.49 | 0.41 |
Mar 26, 2024 | 0.41 | -0.05 | -10.87% | 0.46 | 0.50 | 0.41 |
Mar 25, 2024 | 0.43 | -0.01 | -2.27% | 0.44 | 0.55 | 0.43 |
Mar 22, 2024 | 0.42 | 0.02 | 5.00% | 0.40 | 0.59 | 0.38 |
Feb 21, 2024 | 0.38 | -0.02 | -5.00% | 0.40 | 0.40 | 0.38 |
Feb 20, 2024 | 0.41 | 0.02 | 5.13% | 0.39 | 0.42 | 0.38 |
Feb 12, 2024 | 0.40 | -0.03 | -6.98% | 0.43 | 0.43 | 0.40 |
Feb 9, 2024 | 0.40 | 0.01 | 2.56% | 0.39 | 0.41 | 0.39 |
Feb 8, 2024 | 0.38 | 0.00 | 0.00% | 0.38 | 0.39 | 0.38 |
Feb 2, 2024 | 0.39 | 0.00 | 0.00% | 0.39 | 0.39 | 0.39 |
Feb 1, 2024 | 0.39 | 0.00 | 0.00% | 0.39 | 0.39 | 0.39 |
Jan 31, 2024 | 0.39 | 0.00 | 0.00% | 0.39 | 0.40 | 0.39 |
Jan 30, 2024 | 0.39 | 0.00 | 0.00% | 0.39 | 0.40 | 0.39 |
Jan 29, 2024 | 0.39 | -0.01 | -2.50% | 0.40 | 0.41 | 0.38 |
Jan 26, 2024 | 0.39 | -0.02 | -4.88% | 0.41 | 0.41 | 0.39 |
Jan 25, 2024 | 0.40 | 0.00 | 0.00% | 0.40 | 0.42 | 0.40 |
Jan 24, 2024 | 0.39 | -0.02 | -4.88% | 0.41 | 0.41 | 0.39 |
Jan 23, 2024 | 0.41 | -0.04 | -8.89% | 0.45 | 0.46 | 0.40 |
Jan 22, 2024 | 0.46 | -0.34 | -42.50% | 0.80 | 0.80 | 0.46 |
Jan 19, 2024 | 0.79 | -0.04 | -4.82% | 0.83 | 0.86 | 0.79 |
Virios Therapeutics, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
沒有活動安排 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 12.3153 | 15.6409 | 10.0054 | 2.1785 | 1.9615 |
銷售/一般/行政費用,總計 | 4.24568 | 4.84525 | 9.81138 | 1.34232 | 1.10739 |
研究與開發 | 8.06963 | 10.7957 | 0.19401 | 0.83618 | 0.85411 |
營業收入 | -12.3153 | -15.6409 | -10.0054 | -2.1785 | -1.9615 |
利息收入(費用),非經營淨值 | 0.06748 | -0.31933 | -0.38422 | -0.29513 | -0.1521 |
其他,淨值 | 0.04322 | 0 | 0.00001 | ||
稅前淨收入 | -12.2478 | -15.9603 | -10.3464 | -2.47363 | -2.11359 |
稅後淨收入 | -12.2478 | -15.9603 | -10.3464 | -2.47363 | -2.11359 |
未計算非常項目前的淨收益 | -12.2478 | -15.9603 | -10.3464 | -2.47363 | -2.11359 |
淨收入 | -12.2478 | -15.9603 | -10.3464 | -2.47363 | -2.11359 |
普通股股東可獲收益 (不含非經常性項目) | -12.2478 | -15.9603 | -10.3464 | -2.47363 | -2.11359 |
普通股股東可獲收益 (含非經常性項目) | -12.2478 | -15.9603 | -10.3464 | -2.47363 | -2.11359 |
攤薄淨收入 | -12.2478 | -15.9603 | -10.3464 | -2.47363 | -2.11359 |
攤薄後加權平均股 | 11.0701 | 8.32931 | 8.30508 | 7.83249 | 7.83249 |
扣除特別項目的每股攤薄盈利 | -1.10639 | -1.91616 | -1.24579 | -0.31582 | -0.26985 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
每股正常攤薄盈利 | -1.10639 | -1.91616 | -1.24579 | -0.31582 | -0.26985 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 1.47722 | 1.55729 | 2.08972 | 2.59232 | 3.67206 |
銷售/一般/行政費用,總計 | 0.91937 | 1.05957 | 0.818 | 0.96995 | 1.26562 |
研究與開發 | 0.55784 | 0.49771 | 1.27171 | 1.62237 | 2.40644 |
營業收入 | -1.47722 | -1.55729 | -2.08972 | -2.59232 | -3.67206 |
利息收入(費用),非經營淨值 | 0.03631 | 0.04042 | 0.04516 | 0.01661 | 0.0048 |
稅前淨收入 | -1.4409 | -1.51686 | -2.04456 | -2.57572 | -3.66726 |
稅後淨收入 | -1.4409 | -1.51686 | -2.04456 | -2.57572 | -3.66726 |
未計算非常項目前的淨收益 | -1.4409 | -1.51686 | -2.04456 | -2.57572 | -3.66726 |
淨收入 | -1.4409 | -1.51686 | -2.04456 | -2.57572 | -3.66726 |
普通股股東可獲收益 (不含非經常性項目) | -1.4409 | -1.51686 | -2.04456 | -2.57572 | -3.66726 |
普通股股東可獲收益 (含非經常性項目) | -1.4409 | -1.51686 | -2.04456 | -2.57572 | -3.66726 |
攤薄淨收入 | -1.4409 | -1.51686 | -2.04456 | -2.57572 | -3.66726 |
攤薄後加權平均股 | 18.4114 | 18.3304 | 11.0701 | 18.3304 | 8.33039 |
扣除特別項目的每股攤薄盈利 | -0.07826 | -0.08275 | -0.18469 | -0.14052 | -0.44023 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.07826 | -0.08275 | -0.18469 | -0.14052 | -0.44023 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 8.36976 | 15.7767 | 31.4727 | 0.3159 | 0.0424 |
現金和短期投資 | 7.03099 | 14.0082 | 29.7954 | 0.30938 | 0.03003 |
現金 | 7.03099 | 14.0082 | 29.7954 | 0.30938 | 0.03003 |
預付的費用 | 1.33876 | 1.7685 | 1.67737 | 0.00652 | 0.01237 |
總資産 | 8.36976 | 15.7767 | 31.4727 | 0.3159 | 0.06594 |
其他長期資産,總計 | 0 | 0.02354 | |||
流動負債總額 | 1.04326 | 1.27562 | 1.53184 | 1.62087 | 1.32633 |
應付賬款 | 0.57316 | 0.35386 | 0.36891 | 0.03542 | 0.14566 |
預提費用 | 0.4701 | 0.92176 | 1.16294 | 1.58545 | 1.18068 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
負債總額 | 1.04326 | 1.27562 | 1.53184 | 5.25841 | 1.32633 |
長期債務總額 | 0 | 0 | 0 | 3.63754 | 0 |
長期債務 | 0 | 3.63754 | 0 | ||
股權 | 7.32649 | 14.5011 | 29.9409 | -4.94251 | -1.2604 |
Preferred Stock - Non Redeemable, Net | 0 | 0.075 | 1.28348 | ||
普通股 | 0.00183 | 0.00083 | 0.00083 | 12.6012 | 12.6012 |
留存收益(累計赤字) | -56.1732 | -43.9254 | -27.9651 | -17.6187 | -15.1451 |
總負債和股東權益 | 8.36976 | 15.7767 | 31.4727 | 0.3159 | 0.06594 |
已發行普通股總數 | 18.3304 | 8.33039 | 8.30508 | 7.83249 | 7.83249 |
額外實收資本 | 63.4979 | 58.4256 | 57.9052 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
流動資産總額 | 5.21212 | 6.52062 | 8.36976 | 10.858 | 9.0401 |
現金和短期投資 | 4.59013 | 5.33254 | 7.03099 | 9.7884 | 7.69504 |
現金 | 4.59013 | 5.33254 | 7.03099 | 9.7884 | 7.69504 |
預付的費用 | 0.62199 | 1.18808 | 1.33876 | 1.06958 | 1.34506 |
總資産 | 5.21212 | 6.52062 | 8.36976 | 10.858 | 9.0401 |
流動負債總額 | 0.52003 | 0.54929 | 1.04326 | 1.63314 | 1.89773 |
應付賬款 | 0.21431 | 0.13509 | 0.57316 | 0.67942 | 0.66554 |
預提費用 | 0.30573 | 0.4142 | 0.4701 | 0.95373 | 1.23219 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
負債總額 | 0.52003 | 0.54929 | 1.04326 | 1.63314 | 1.89773 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
股權 | 4.69209 | 5.97133 | 7.32649 | 9.22484 | 7.14236 |
Preferred Stock - Non Redeemable, Net | |||||
普通股 | 0.00186 | 0.00183 | 0.00183 | 0.00183 | 0.00083 |
額外實收資本 | 64.1134 | 63.6596 | 63.4979 | 63.3517 | 58.6945 |
留存收益(累計赤字) | -59.131 | -57.6901 | -56.1732 | -54.1287 | -51.5529 |
總負債和股東權益 | 5.21212 | 6.52062 | 8.36976 | 10.858 | 9.0401 |
已發行普通股總數 | 18.6085 | 18.3304 | 18.3304 | 18.3304 | 8.33039 |
Treasury Stock - Common | -0.29224 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -12.2478 | -15.9603 | -10.3464 | -2.47363 | -2.11359 |
經營活動産生的現金 | -11.4678 | -15.6896 | -3.8952 | -2.09215 | -1.19596 |
非現金物品 | 0.58266 | 0.32288 | 7.42526 | 0.065 | 0.04851 |
營運資金的變化 | 0.19738 | -0.05219 | -0.97406 | 0.31648 | 0.86913 |
融資活動産生的現金 | 4.49061 | -0.0976 | 33.3812 | 2.37151 | 1.15047 |
融資現金流項目 | 4.49061 | -0.29517 | -0.13826 | -0.05849 | 1.15047 |
債務的發行(退還),淨額 | 0 | 1.99413 | 2.43 | 0 | |
現金淨變化 | -6.97719 | -15.7872 | 29.486 | 0.27936 | -0.04549 |
已付現金利息 | 0 | 0.01255 | |||
股票的發行(報廢),淨額 | 0 | 0.19756 | 31.5253 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -1.51686 | -12.2478 | -10.2033 | -7.62756 | -3.96031 |
Cash From Operating Activities | -1.69845 | -11.4678 | -8.79639 | -6.31314 | -2.65602 |
Non-Cash Items | 0.1617 | 0.58266 | 0.43313 | 0.26886 | 0.13191 |
Changes in Working Capital | -0.34328 | 0.19738 | 0.97376 | 1.04556 | 1.17239 |
Cash From Financing Activities | 0 | 4.49061 | 4.5766 | 0 | 0 |
Financing Cash Flow Items | 0 | 4.49061 | 4.5766 | 0 | 0 |
Issuance (Retirement) of Stock, Net | 0 | 0 | 0 | 0 | |
Issuance (Retirement) of Debt, Net | |||||
Net Change in Cash | -1.69845 | -6.97719 | -4.21979 | -6.31314 | -2.65602 |
Cash Interest Paid |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Bio Therapeutic Drugs |
44 Milton Avenue
ALPHARETTA
GEORGIA 30009
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 580.000 多名交易者,選擇與 Capital.com 交易